Pro-Dex (co) Long Term Debt

As of the most recent data (March 2026), PDEX shows a long-term debt of $15M. That compares with $11M in the prior-year period — up 41.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PDEX's long-term debt is now $15M (was $11M) — a 41.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Pro-Dex (co) is outperforming or lagging.

Tracking PDEX's long-term debt over time shows whether Pro-Dex (co) is scaling, shrinking, or reshaping that part of the business. The current reading is $15M That compares with $11M in the prior-year period — up 41.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Pro-Dex (co)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $15M) with ownership activity and broader fundamentals.

Pro-Dex (co)'s long-term debt is $15M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.